Cargando…
Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study
OBJECTIVE: Neuronata-R® (lenzumestrocel) is an autologous bone marrow-derived mesenchymal stem cell (BM-MSC) product, which was conditionally approved by the Korean Ministry of Food and Drug Safety (KMFDS, Republic of Korea) in 2013 for the treatment of amyotrophic lateral sclerosis (ALS). In the pr...
Autores principales: | Nam, Jae-Yong, Chun, Sehwan, Lee, Tae Yong, Seo, Yunjeong, Kim, Kwijoo, Park, Jinseok, Sung, Wonjae, Oh, Ki-Wook, Lee, Sanggon, Park, Jin-Sung, Oh, Juyeon, Chung, Kyung Cheon, An, Hyonggin, Chu, Hyeon Sik, Son, Bugyeong, Kim, Seung Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130504/ https://www.ncbi.nlm.nih.gov/pubmed/37122380 http://dx.doi.org/10.3389/fnagi.2023.1148444 |
Ejemplares similares
-
Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial
por: Nam, Jae-Yong, et al.
Publicado: (2022) -
Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants
por: Sung, Wonjae, et al.
Publicado: (2022) -
Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018) -
An analysis of variants in TARDBP in the Korean population with amyotrophic lateral sclerosis: comparison with previous data
por: Sung, Wonjae, et al.
Publicado: (2023) -
Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)